These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28731016)

  • 1. Hidradenitis suppurativa unresponsive to canakinumab treatment: A case report.
    Tekin B; Salman A; Ergun T
    Indian J Dermatol Venereol Leprol; 2017; 83(5):615-617. PubMed ID: 28731016
    [No Abstract]   [Full Text] [Related]  

  • 2. Canakinumab for Severe Hidradenitis Suppurativa: Preliminary Experience in 2 Cases.
    Houriet C; Seyed Jafari SM; Thomi R; Schlapbach C; Borradori L; Yawalkar N; Hunger RE
    JAMA Dermatol; 2017 Nov; 153(11):1195-1197. PubMed ID: 28854317
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab.
    Schuch A; Fischer T; Boehner A; Biedermann T; Volz T
    Acta Derm Venereol; 2018 Jan; 98(1):151-152. PubMed ID: 28902952
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum and concomitant hidradenitis suppurativa--rapid response to canakinumab (anti-IL-1β).
    Jaeger T; Andres C; Grosber M; Zirbs M; Hein R; Ring J; Traidl-Hoffmann C
    Eur J Dermatol; 2013; 23(3):408-10. PubMed ID: 23816498
    [No Abstract]   [Full Text] [Related]  

  • 6. The cutting edge. Severe hidradenitis suppurativa treated with adalimumab.
    Moul DK; Korman NJ
    Arch Dermatol; 2006 Sep; 142(9):1110-2. PubMed ID: 16982997
    [No Abstract]   [Full Text] [Related]  

  • 7. Guselkumab in the treatment of hidradenitis suppurativa: A retrospective chart review.
    Casseres RG; Kahn JS; Her MJ; Rosmarin D
    J Am Acad Dermatol; 2019 Jul; 81(1):265-267. PubMed ID: 30562567
    [No Abstract]   [Full Text] [Related]  

  • 8. Association and management of Crohn's disease plus hidradenitis suppurativa.
    dos Santos CH; Netto PO; Kawaguchi KY; Parreira Alves JA; de Alencar Souza VP; Reverdito S
    Inflamm Bowel Dis; 2012 Apr; 18(4):E801-2. PubMed ID: 21993924
    [No Abstract]   [Full Text] [Related]  

  • 9. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate.
    De Souza A; Solomon GE; Strober BE
    Bull NYU Hosp Jt Dis; 2011; 69(2):185-7. PubMed ID: 22035400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.
    Alecsandru D; Padilla B; Izquierdo JA; Fernández-Cruz E; Sánchez-Ramón S
    Arch Dermatol; 2010 Dec; 146(12):1343-5. PubMed ID: 21173317
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term infliximab for severe hidradenitis suppurativa.
    Thielen AM; Barde C; Saurat JH
    Br J Dermatol; 2006 Nov; 155(5):1105-7. PubMed ID: 17034567
    [No Abstract]   [Full Text] [Related]  

  • 13. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hidradenitis suppurativa treated with infliximab].
    Obadia DL; Daxbacher EL; Jeunon T; Gripp AC
    An Bras Dermatol; 2009; 84(6):695-7. PubMed ID: 20191188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review.
    Meskin SW; Carlson EM
    Ocul Immunol Inflamm; 2011 Oct; 19(5):340-2. PubMed ID: 21823931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of the efficacy and adverse events associated with infliximab treatment of hidradenitis suppurativa in patients with coexistent inflammatory diseases.
    Machet L; Samimi M; Delage M; Paintaud G; Maruani A
    J Am Acad Dermatol; 2013 Oct; 69(4):649-50. PubMed ID: 24034373
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe hidradenitis suppurativa treated with infliximab infusion.
    Adams DR; Gordon KB; Devenyi AG; Ioffreda MD
    Arch Dermatol; 2003 Dec; 139(12):1540-2. PubMed ID: 14676068
    [No Abstract]   [Full Text] [Related]  

  • 18. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
    Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
    Ingram JR; Burton T
    Br J Dermatol; 2017 Feb; 176(2):281-282. PubMed ID: 28244073
    [No Abstract]   [Full Text] [Related]  

  • 20. Variable response of hidradenitis suppurativa to infliximab in four patients.
    Usmani N; Clayton TH; Everett S; Goodfield MD
    Clin Exp Dermatol; 2007 Mar; 32(2):204-5. PubMed ID: 17342798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.